2003
Kyle Harper says SARS-CoV-1 in 2003 was slightly more virulent and made people sick quickly, which made it easier to contain than COVID-19.
“Like the first COVID, SARS-CoV-1, 2003, slightly more virulent. And in fact, it was just more virulent enough that it made you sick pretty quick.”
Kyle Harper · Why Rome actually fell: plagues, slavery, & ice age — Kyle Harper, 1:14:52
2020
Andrew von Eschenbach says monoclonal antibodies could be developed from antibodies made by people who have recovered from the coronavirus.
“develop monoclonal antibodies by finding people who have conquered the virus, have already made an antibody within their own system to destroy or fight off that virus.”
Andrew von Eschenbach · Ep. 8: Legacy, with former FDA Commissioner Andrew von Eschenbach, 0:06:27
2020
Andrew von Eschenbach says real-world patient data must be acquired, aggregated and analyzed to learn how off-the-shelf drugs work against COVID-19.
“we'll have to capitalize on the opportunity to acquire, aggregate, and analyze real-world data”
Andrew von Eschenbach · Ep. 8: Legacy, with former FDA Commissioner Andrew von Eschenbach, 0:10:09
2020
Shah says Washington State had the first COVID-19 case in the continental United States, along with the first outbreak and first death.
“this was the state that had the first case in the continental United States, had the first outbreak and the first death.”
Umair Shah · Reimagining healthcare delivery and public health with AI, 0:08:21
2020
Shah says that during the COVID-19 emergency many U.S. public health agencies were still using fax machines to receive data.
“a lot of agencies across the country were still using fax machines, you know, to get data that were coming in.”
Umair Shah · Reimagining healthcare delivery and public health with AI, 0:25:16
2020
Peter Lee asked whether the first U.S. COVID-19 patient was detected through the Seattle Flu Study's surveillance, and Shah agreed.
“wasn't a patient number one in the united states discovered also because of the seattle flu study or at least that sort of syndromic surveillance”
Umair Shah · Reimagining healthcare delivery and public health with AI, 0:30:01
2021
Bob Nelsen argues the world's pandemic response was inadequate, noting it took about a year and roughly half a million deaths in the US to reach vaccines.
“It only took a year and a half a million dead people, right?”
Bob Nelsen · Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing, 0:23:30
Undated
Allan Shaw says the industry went from discovery to available COVID-19 vaccines in less than a year.
“in less than a year, we've been able to go from discovery to actually having drugs available to vaccinate against COVID-19”
Allan Shaw · A CFO's Prescription For Biopharma Success With Allan Shaw, 0:02:59
Undated
Amy Abernethy says the COVID-19 genome was sequenced and published for scientists worldwide within 24 hours, which enabled rapid mRNA vaccine development.
“essentially sequencing the genome, publishing it for scientists all around the world to use within 24 hours, and then moving from there.”
Amy Abernethy · AI, Innovation, and Regulatory Insights with Amy Abernethy, 0:03:04
Undated
Amy Abernethy says data from Israel's health systems was used to study how long COVID-19 vaccine effectiveness lasts, safety signals and the need for boosters.
“we leveraged, for example, data from the Israel health systems to understand duration of effectiveness and safety signals and do you need a booster.”
Amy Abernethy · AI, Innovation, and Regulatory Insights with Amy Abernethy, 0:03:35
Undated
Shah says Washington State ended up with the fifth lowest COVID-19 death rate in the United States.
“we had the fifth lowest death rate in the U.S., and that was because we all came together to do so much.”
Umair Shah · Reimagining healthcare delivery and public health with AI, 0:08:58
Undated
Collaborating with consumer genetics companies during COVID, Regeneron found genetic factors tied to severe COVID and hospitalization, and also protective factors, and published them.
“We found important genetic factors that could really put you at really high risk of getting severe COVID and hospitalizations.”
Aris Baras · Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D., 0:30:56